Double-click here to edit the text.

25 years of experience in retrovirology, 14 years in industry, author or co-author of more than 100 scientific publications. Consultant or reviewer for a number of international scientific journals. After 10 years in academia at Research Institutes in Switzerland, the U.S. and at the Ludwig-Maximilians-University Munich, Dr. Salmons joined Bavarian Nordic as their first Scientific Director 1994-2000, He became CEO of Austrian-Nordic Biotherapeutics AG 2000-2001 and was directly responsible for the phase I/II clinical trial of NovaCaps®. After founding and managing the scientific direction of AUSTRIANOVA Biotechnology GmbH and AUSTRIANOVA Biomanufacturing AG over the period 2001 to 2008, he was appointed Managing Director of AUSTRIANOVA Singapore Pte Ltd on its founding in March 2007. In June 2008, as a result of a MBO, Dr. Salmons resigned his positions with the European companies and became owner, President and full time CEO of the Singapore company. Together with Prof. Günzburg, Dr. Salmons is the co-inventor of a number of important international patents and patent applications pertaining to SGAUSTRIA’s technology.

Professor of Virology, Head of the Institute for Virology at the University of Veterinary Medicine, Vienna. Director of the Christian Doppler Laboratory for Gene Therapeutic Vector Development in Vienna and Singapore. Previous Chairman of the supervisory board of AUSTRIANOVA Biotechnology GmbH and AUSTRIANOVA Biomanufacturing AG, as well as of Virusure GmbH. Prof. Günzburg has more than 20 years experience in virology, and over thirteen years experience in cell therapy and bioencapsulation, has published numerous peer reviewed scientific publications and book chapters in the field and is inventor of 17 patents and patent applications. He is a member of the editorial board of a number of international gene and cell therapy journals. In the past he has served as chief scientific consultant for Bavarian Nordic A/S as well as being the founding member of the Austrian Network for Gene Therapy.